Hayden Royal’s Bionano Genomics BNGO Stock Holding History

Hayden Royal’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-23	Closed	-$112K	–	211
2021 Q1	$112K	Buy	+23	New	+$130K	0.06%	196

Other funds holding BNGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Hayden Royal's BNGO Position: Q2 2021 in Review

Hayden Royal sold out of Bionano Genomics (BNGO) in Q2 2021, closing a stake of 23 shares — an estimated $112K sold.

Hayden Royal first reported a position in BNGO in Q1 2021 and held it in 1 quarter. The position peaked at $112K in Q1 2021. 152 funds tracked by Wall St. Rank hold BNGO as of Q2 2021.

Hayden Royal reported no remaining Bionano Genomics position as of Q2 2021 after selling out during the quarter.
Hayden Royal sold 23 Bionano Genomics shares in Q2 2021, an estimated $112K.
Hayden Royal first reported a position in Bionano Genomics in Q1 2021 and held it in 1 quarter.
Hayden Royal's Bionano Genomics position peaked at $112K in Q1 2021.
152 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2021.

Based on Hayden Royal's 13F filing for Q2 2021, filed 11 Aug 2021.